Literature DB >> 15190867

[Postoperative nausea and vomiting].

C C Apfel1, N Roewer.   

Abstract

Numerous pathophysiological mechanisms are known to cause nausea or vomiting but their role for postoperative nausea and vomiting (PONV) is not quite clear. Volatile anesthetics, nitrous oxide and opioids appear to be the most important causes for PONV. Female gender, non-smoking and a history of motion sickness and PONV are the most important patient specific risk factors. With these risk factors an objective risks assessment is achievable as a good rational basis for a risk dependent antiemetic approach: When the risk is low, moderate, or high, the use of none, a single or a combination of prophylactic antiemetic interventions seems to be justified. Performing a total intravenous anesthesia (Ti.v.A) with propofol is a reasonable prophylactic approach, but does not solve the problem satisfactorily alone if the risk is very high, reducing the risk of PONV only by 30%. This is comparable to the reduction rate of antiemetics, such as serotonin antagonist, dexamethasone and droperidol. It must be stressed that metoclopramide is ineffective. Data from IMPACT indicate that prophylaxis is not very effective if the patients risk is low. At a moderate risk the use of Ti.v.A or an antiemetic is reasonable and only a (very) high risk justifies the combination of several prophylactic antiemetic interventions. For the treatment of PONV an antiemetic should be chosen which has not been used prophylactically. The necessary doses are usually a quarter of those needed for prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15190867     DOI: 10.1007/s00101-004-0662-8

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  66 in total

1.  An international multicenter protocol to assess the single and combined benefits of antiemetic interventions in a controlled clinical trial of a 2x2x2x2x2x2 factorial design (IMPACT).

Authors:  Christian C Apfel; Kari Korttila; Mona Abdalla; Andreas Biedler; Peter Kranke; Stuart J Pocock; N Roewer
Journal:  Control Clin Trials       Date:  2003-12

Review 2.  [Postoperative nausea and vomiting].

Authors:  A Biedler; W Wilhelm
Journal:  Anaesthesist       Date:  1998-02       Impact factor: 1.041

3.  A survey of postoperative nausea and vomiting.

Authors:  M Koivuranta; E Läärä; L Snåre; S Alahuhta
Journal:  Anaesthesia       Date:  1997-05       Impact factor: 6.955

4.  Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial.

Authors:  A L Kovac; T A O'Connor; M H Pearman; L J Kekoler; D Edmondson; V L Baughman; J J Angel; C Campbell; H G Jense; M Mingus; M B Shahvari; M R Creed
Journal:  J Clin Anesth       Date:  1999-09       Impact factor: 9.452

5.  [The incidence of postoperative nausea and vomiting is not effected by routinely applied manual pre-oxygenation during induction of anesthesia].

Authors:  A Hechler; F Naujoks; K Ataman; H B Hopf
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  1999-11       Impact factor: 0.698

6.  The antiemetic efficacy of droperidol added to morphine patient-controlled analgesia: a randomized, controlled, multicenter dose-finding study.

Authors:  Xavier Culebras; Jean-Baptiste Corpataux; Giovanni Gaggero; Martin R Tramèr
Journal:  Anesth Analg       Date:  2003-09       Impact factor: 5.108

7.  Logistic regression analysis of fixed patient factors for postoperative sickness: a model for risk assessment.

Authors:  M Palazzo; R Evans
Journal:  Br J Anaesth       Date:  1993-02       Impact factor: 9.166

8.  Morphine 6-glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret.

Authors:  P I Thompson; S Bingham; P L Andrews; N Patel; S P Joel; M L Slevin
Journal:  Br J Pharmacol       Date:  1992-05       Impact factor: 8.739

9.  Antiemetic prophylaxis does not improve outcomes after outpatient surgery when compared to symptomatic treatment.

Authors:  P E Scuderi; R L James; L Harris; G R Mims
Journal:  Anesthesiology       Date:  1999-02       Impact factor: 7.892

10.  The efficacy and safety of transdermal scopolamine for the prevention of postoperative nausea and vomiting: a quantitative systematic review.

Authors:  Peter Kranke; Astrid M Morin; Norbert Roewer; Hinnerk Wulf; Leopold H Eberhart
Journal:  Anesth Analg       Date:  2002-07       Impact factor: 5.108

View more
  16 in total

Review 1.  ["Asleep-awake-asleep"-anaesthetic technique for awake craniotomy].

Authors:  U Schulz; D Keh; G Fritz; C Barner; T Kerner; G-H Schneider; T Trottenberg; A Kupsch; W Boemke
Journal:  Anaesthesist       Date:  2006-05       Impact factor: 1.041

2.  [Elective colon resection in Germany. A survey of the perioperative anesthesiological management].

Authors:  T Hasenberg; M Niedergethmann; P Rittler; S Post; K W Jauch; M Senkal; C Spies; W Schwenk; E Shang
Journal:  Anaesthesist       Date:  2007-12       Impact factor: 1.041

3.  Ondansetron, metoclopramid, dexamethason, and their combinations compared for the prevention of postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: a prospective randomized study.

Authors:  K Leksowski; P Peryga; R Szyca
Journal:  Surg Endosc       Date:  2006-05-11       Impact factor: 4.584

4.  [Complications and emergencies in the recovery room].

Authors:  N Hausknecht; U Berwanger; D Conrad; S Kleinschmidt; W Armbruster
Journal:  Anaesthesist       Date:  2021-03       Impact factor: 1.041

5.  [Perioperative patient management. Evaluation of subjective stress and demands of patients undergoing elective gynaecological surgery].

Authors:  B Gauter-Fleckenstein; R Kaviani; C Weiss; A Burges; M Korell; C Anthuber; H-D Hermann; E Weninger; U Kreimeier
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 6.  [Long QT syndrome and anaesthesia].

Authors:  S Rasche; T Koch; M Hübler
Journal:  Anaesthesist       Date:  2006-03       Impact factor: 1.041

7.  [EEG-adjusted target-controlled infusion : Propofol target concentration with different doses of remifentanil].

Authors:  N Büttner; B Schultz; U Grouven; A Schultz
Journal:  Anaesthesist       Date:  2010-02       Impact factor: 1.041

Review 8.  [Nitrous oxide. Sense or nonsense for today's anaesthesia].

Authors:  M E Schönherr; M W Hollmann; B Graf
Journal:  Anaesthesist       Date:  2004-09       Impact factor: 1.041

9.  [Outpatient opiate therapy in cancer patients during their last days of life].

Authors:  R Maier; A Maier; C Müller-Busch
Journal:  Schmerz       Date:  2008-04       Impact factor: 1.107

Review 10.  [Nausea and vomiting in the postoperative phase. Expert- and evidence-based recommendations for prophylaxis and therapy].

Authors:  C C Apfel; P Kranke; S Piper; D Rüsch; H Kerger; M Steinfath; K Stöcklein; D R Spahn; T Möllhoff; K Danner; A Biedler; M Hohenhaus; B Zwissler; O Danzeisen; H Gerber; F-J Kretz
Journal:  Anaesthesist       Date:  2007-11       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.